Complete decongestive therapy for breast cancer-related lymphedema: An evidence summary
Asia-Pacific Journal of Oncology Nursing · 2026-12 · 13 · 101011
DOI: 10.1016/j.apjon.2026.101011 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Asia-Pacific Journal of Oncology Nursing, 2026-12. Verfasst von Chenxi Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nursing, Fudan University Shanghai Cancer Center, Shanghai, China. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shanghai Anti-Cancer Association.
Abstract (Originalsprache)
Objective
To identify, appraise, and synthesize the best available evidence on complete decongestive therapy (CDT) for people with breast cancer-related lymphedema (BCRL).
Methods
Using an evidence-based health care pyramid approach, we searched bibliographic databases, guideline and professional organization websites, and clinical decision support sources from inception to October 1, 2025. Eligibility was defined using the PIPOST framework. Methodological quality was independently appraised by three reviewers for guidelines and by two reviewers for other evidence types using evidence-type-specific appraisal tools. Two reviewers extracted and synthesized the evidence. Evidence levels were assigned using the JBI 2014 system, and recommendation grades were determined through expert-panel assessment of feasibility, appropriateness, meaningfulness, and effectiveness.
Results
Thirty-one evidence sources were included, comprising clinical decision support sources, guidelines, evidence summaries, systematic reviews, and expert consensus documents. Thirty-seven evidence statements were synthesized across three domains: implementation principles, the intensive treatment phase, and the maintenance treatment phase. Nineteen statements (51.4%) were supported by Level 1 evidence, and 25 (67.6%) received Grade A recommendations.
Conclusions
This evidence summary provides an evidence-informed framework for CDT across the intensive and maintenance phases, with explicit attention to transition planning and self-management. The evidence is stronger for several core interventions than for implementation strategies and long-term self-management. Further high-quality primary and implementation research is needed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nursing, Fudan University Shanghai Cancer Center, Shanghai, China.
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Förderung
- Shanghai Anti-Cancer Association
Zitieren
APA
Zhu, C., Cai, M., Li, Y., Hou, S., Zhang, X., & Qiu, J. (2026). Complete decongestive therapy for breast cancer-related lymphedema: An evidence summary. Asia-Pacific Journal of Oncology Nursing, 13, 101011. https://doi.org/10.1016/j.apjon.2026.101011
Vancouver
Zhu C, Cai M, Li Y, Hou S, Zhang X, Qiu J. Complete decongestive therapy for breast cancer-related lymphedema: An evidence summary. Asia-Pacific Journal of Oncology Nursing. 2026;13:101011. doi:10.1016/j.apjon.2026.101011
BibTeX
@article{Zhu2026,
author = {Zhu, Chenxi and Cai, Mingxuan and Li, Yun and Hou, Shengqun and Zhang, Xia and Qiu, Jiajia},
title = {Complete decongestive therapy for breast cancer-related lymphedema: An evidence summary},
journal = {Asia-Pacific Journal of Oncology Nursing},
year = {2026},
volume = {13},
pages = {101011},
doi = {10.1016/j.apjon.2026.101011}
}
EUVIMED